Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_assertion type Assertion NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_head.
- NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_assertion description "[In addition, the genes B7-H1 (p = 0.040), FRA2 (p = 0.035), CD151 (p = 0.004) and BCL2L2 (p = 0.035) showed significantly higher expression in early metastasized than in nonmetastatic tumor samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_provenance.
- NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_assertion evidence source_evidence_literature NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_provenance.
- NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_assertion SIO_000772 21600596 NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_provenance.
- NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_assertion wasDerivedFrom befree-20140225 NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_provenance.
- NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_assertion wasGeneratedBy ECO_0000203 NP484982.RAcDix-o19G8AQIoP8C8-iwknrnDnsblgdZ4RgdSrbJyg130_provenance.